Neuromodulation Devices and Associated Products 2023
Buyers
Value
£392,000,000
Suppliers
- Abbott Medical U.K. Ltd.
- AVANOS MEDICAL UK LIMITED
- Axonics Modulation Technologies UK Ltd
- Boston Scientific Ltd
- BVM MEDICAL LTD
- Charco Neurotech
- electroCore UK Ltd.
- Far From Surgical Solutions
- Flow Neuroscience
- Freedom Neuro BV
- Inspire Medical Systems
- LivaNova UK Limited
- Mainstay Medical; ReActiv8
- Medtronic Limited
- Nevro Medical LTD / Nevro Corp.
- Nyxoah SA
- Optimus Medical Ltd
- P14 Medical ltd/TA Platform 14
- PHAGENESIS LTD
- Polar Medical Ltd
- Precisis GmbH
- Saluda Medical
- Inomed Neurocare Limited
Classifications
- Stimulator
Tags
- award
Submission Deadline
1 year ago
Published
11 months ago
Description
Non-exclusive Framework Agreement (FAG) for the supply to the NHS Supply Chain customer base via the E-Direct Route. Product range to include, but not limited to stimulation of; Deep Brain, Spinal Cord, Sacral Nerve, Vagal Nerve, Dorsal Route Ganglion, Peripheral Nerve, Radio Frequency Pain Management, Intrathecal Brug Delivery Pumps, Dorsal Ramus Medial Branch nerve and other devices that provide nerve stimulation or pain management that meet the requirements of users and patients. The FAG will provide access to Neuromodulation Devices/Consumables that are associated with Neuromodulation procedures. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £92,000,000.00 the term of FAG, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the FAG. The estimated value over the total FAG term (including any extension options) is £392,000,000.00. Additional information: Located in attachments is a Daft version of the Framework Agreement
Similar Contracts
AI Bid Assistant
Our AI-powered tool to help you create winning bids is coming soon!
Timeline complete
Complete